Education
About Us
Working with TipRanks
Follow Us
Steve Williamson Insider Profile
4 Followers
Steve Williamson, SVP, GYN Surgical at Hologic, holds 376.04K shares in Pulmonx (Ticker: LUNG), holds 320.35K shares in Outset Medical (Ticker: OM), holds 41.72K shares in Hologic (Ticker: HOLX).
Profitable Transactions
9 out of 9 Profitable Transactions
Average Return
+68.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Steve Williamson holds in companies
Most Profitable Insider Trade
The most profitable trade made by Steve Williamson
Steve Williamson's Trading History
Hologic
Mar 08, 2012
SVP, GYN Surgical
Informative Sell
74.11K
$2.69M
Outset Medical
Feb 16, 2024
CCO
Informative Sell
8.93K
$191.89K
Pulmonx
Mar 05, 2025
President & CEO, Director
Uninformative Buy
―
$2.81M
List of latest transactions for each holding click on a transaction to see Steve Williamson's performance on stock
You May Also Like
Steve Williamson insider profile FAQ
What is the percentage of profitable transactions made by Steve Williamson?
The percentage of profitable transactions made by Steve Williamson is 100%.
What is the average return per transaction made by Steve Williamson?
The average return per transaction made by Steve Williamson is 68.50%.
What stocks does Steve Williamson hold?
Steve Williamson holds: HOLX, OM, LUNG stocks.
What was Steve Williamson’s latest transaction?
Steve Williamson latest transaction was an Uninformative Buy of ―.
What was Steve Williamson's most profitable transaction?
Steve Williamson’s most profitable transaction was an Informative Sell of OM stock on August 17, 2023. The return on the trade was 95.20%.
What is Steve Williamson's role in Hologic?
Steve Williamson's role in Hologic is SVP, GYN Surgical.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.